DrugPatentWatch Database Preview

Drugs in MeSH Category Nucleic Acid Synthesis Inhibitors

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-008	Mar 24, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-002	Oct 11, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Antares Pharma Inc	OTREXUP PFS	methotrexate	SOLUTION;SUBCUTANEOUS	204824-012	May 31, 2017		DISCN	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-003	Oct 11, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-002	Oct 11, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Roxane	HYDROXYUREA	hydroxyurea	CAPSULE;ORAL	074476-001	Aug 18, 1995		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-001	Oct 11, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration